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The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), emerged in Wuhan city and was declared a pandemic in March 2020. Although the virus is not restricted
to the lung parenchyma, the use of chest imaging in COVID-19 can be especially useful for patients with moderate
to severe symptoms or comorbidities. This article aimed to demonstrate the chest imaging findings of COVID-19 on
different modalities: chest radiography, computed tomography, and ultrasonography. In addition, it intended to
review recommendations on imaging assessment of COVID-19 and to discuss the use of a structured chest
computed tomography report. Chest radiography, despite being a low-cost and easily available method, has low
sensitivity for screening patients. It can be useful in monitoring hospitalized patients, especially for the evaluation
of complications such as pneumothorax and pleural effusion. Chest computed tomography, despite being highly
sensitive, has a low specificity, and hence cannot replace the reference diagnostic test (reverse transcription
polymerase chain reaction). To facilitate the confection and reduce the variability of radiological reports, some
standardizations with structured reports have been proposed. Among the available classifications, it is possible to
divide the radiological findings into typical, indeterminate, atypical, and negative findings. The structured report
can also contain an estimate of the extent of lung involvement (e.g., more or less than 50% of the lung
parenchyma). Pulmonary ultrasonography can also be an auxiliary method, especially for monitoring hospitalized
patients in intensive care units, where transfer to a tomography scanner is difficult.
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’ INTRODUCTION
In December 2019, an outbreak of a highly contagious
pneumonia of unknown etiology was reported in the city
of Wuhan, China, with many infected patients presenting
severe acute respiratory syndrome (SARS). It quickly spread
to other countries and was declared a pandemic in March
2020 by the World Health Organization (1,2). The etiological
agent, identified from epithelial cells of infected patients’
airways, was a coronavirus (SARS-CoV-2), belonging to
subgenus Sarbecovirus and subfamily Orthocoronavirinae,
the seventh member of the coronavirus family that is known
to infect humans (1). The infection was named coronavirus
disease (COVID-19).
COVID-19 pneumonia shares etiological and clinical simi-
larities to other contemporary syndromes also caused by coro-
naviruses, including the Middle East Respiratory Syndrome
(MERS), identified in 2012, and SARS, in 2003 (3). Similar to
other viral infectious diseases, COVID-19 is not restricted to
the pulmonary parenchyma, with reports of myocarditis,
hypercoagulability status, acute renal failure, mesenteric
lymphadenitis, and encephalitis (4).
This article aimed to demonstrate the chest imaging find-
ings of COVID-19 on different modalities, to review national
and international recommendations on imaging assessment
of COVID-19 (5-9), and to discuss the use of a structured chest
computed tomography (CT) report for the disease.
’ ROLE OF IMAGING IN COVID-19 PULMONARY
INFECTION
Chest imaging should be carefully indicated in patients
with suspected COVID-19 infection not only to reduce the
patient
́
s radiation exposure but also to reduce unnecessary
exposure of other patients and healthcare workers, and to
rationalize the use of personal protective equipment and
resources for disinfecting the patient care equipment (9).
The use of chest imaging in COVID-19 suspected cases
does not replace specific diagnostic tests such as the detec-
tion of viral RNA by reverse transcription polymerase chain
reaction (RT-PCR) and serological detection of antibodies to
SARS-CoV-2. Moreover, most medical societies do not
recommend the use of imaging as a method of disease screen-
ing (5-8,10). In general, it is not indicated for asymptomaticDOI: 10.6061/clinics/2020/e2027
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patients or those with mild symptoms of the disease. Imaging
should be reserved for those with moderate to severe symp-
toms, those with risk of progression (presence of comorbid-
ities), and those with worsening of the respiratory condition
(Figure 1). In environments with limited resources, imaging
can eventually be indicated as a method for medical triage of
patients with moderate to severe clinical features and a high
pre-test probability (9), in whom urgent decision-making is of
primary importance.
Notably, there is an overlap of chest imaging findings in
COVID-19 and other diseases (8). In addition, pulmonary
imaging features can persist for weeks to months and should
not be an objection factor for patient discharge (5), nor should
it be considered as a treatment control method (6). In general,
the resolution of the imaging findings is observed at approxi-
mately the 26th day of symptom onset in patients with
COVID-19 pneumonia (6), but in some cases, it can take even
longer.
’ CHEST RADIOGRAPHY
Chest radiography is a quick and easy method, frequently
requested due to its wide availability and low cost. The advent
Figure 1 - Recommendations for performing imaging in patients with COVID-19 pneumonia. Adapted from Rubin et al (9).
*Age 465 years, cardiovascular diseases, hypertension, chronic respiratory diseases, diabetes, and immunosuppression.
Figure 2 - Chest radiography (A), posteroanterior view, shows retrocardiac and right peri diaphragmatic opacities (arrow), regions
which are often neglected in the radiographic evaluation; there are no other notable parenchymal changes. Coronal (B) and axial
(C and D) CT images on the same day show ground glass opacities associated with some consolidations in the posterior regions of both
lungs, most prominent in the lower lobes. Note the slight thickening of the inter and intralobular septa that constitute the crazy-
paving pattern in the right lung base (arrowhead).
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of portable devices has allowed its use in intensive care units
and field hospitals (7).
Radiologists and clinicians should be aware of the radio-
graphy limitation of COVID-19 pneumonia due to the low
sensitivity, estimated at 25% (11), especially in initial cases
(Figure 2). Therefore, it should not be considered as a
screening method (7). It is recommended for selected popu-
lations, such as hospitalized patients to assess disease pro-
gression (Figure 3) or to assess associated complications,
such as ventilator-associated pneumonia, pleural effusion, or
pneumothorax (9).
The main radiographic findings are lung opacities with
bilateral distribution and predominance in the periphery and
lower pulmonary fields (12). The disease extension can be
quantified utilizing adapted scores according to the percentage
of pulmonary opacity extension (12). It is noteworthy that
such information can be either under-detected or under-
estimated when compared to CT, thus limiting the disease
monitoring capability of radiography (11).
’ CHEST COMPUTED TOMOGRAPHY
In the context of the COVID-19 pandemic, the use of
CT has increased significantly, despite the aforementioned
national and international recommendations. It should be
performed in hospitalized and symptomatic patients with
Figure 3 - Chest radiographs, posteroanterior views (A and B) and in bed (C), performed at intervals of 2 days, show progression of the
diffuse and bilateral pulmonary opacities. Note the tracheal cannula and other vital devices (C).
Figure 4 - Recommendations for categorizing computed tomography findings of COVID-19 pneumonia. Adapted from Simpson et al (8).
Table 1 - Adapted Proposed Reporting Language for CT Findings Related to COVID-19 used in the Hospital das Clı́nicas da Faculdade
de Medicina da USP.
Appearance Suggested reporting language
Typical Imaging features are suggestive of pneumonia and viral etiology must be included in the
etiological differential diagnosis, particularly COVID-19.
Indeterminate Imaging features are nonspecific and can be found in a variety of infectious and non-infectious
processes, including cases of viral pneumonia and COVID-19.
Atypical Imaging features suggest pulmonary inflammation/infection, although its pattern is not usually
reported in COVID-19 cases. Other etiological agents should be considered initially.
Negative for pneumonia No CT findings suggestive of pulmonary inflammation/infection. Note: CT may be negative in
some early stages of COVID-19.
3
CLINICS 2020;75:e2027 Imaging findings in COVID-19 pneumonia
Farias LPG et al.
clinical worsening and/or patients who have comorbidities
(5-8,10). In these patients, CT is indicated mainly to assess the
extent of the disease and to identify complications, such as
pulmonary thromboembolism or overlapping bacterial infec-
tion, and to evaluate differential diagnoses (6).
When compared to the reference diagnostic test (RT-PCR),
CT has high sensitivity (97%), but low specificity (25%) (13),
and hence cannot replace it (7). The tomographic findings
considered typical of COVID-19 are ground glass opacities
(GGOs), consolidations and crazy-paving pattern (Figure 2)
with bilateral and multifocal distribution, and a peripheral
and posterior predominance (14-16). Such findings are not
exclusive to COVID-19 and can be found in other viral pneu-
monias, connective tissue lung disease, and drug-induced
lung disease (8). Therefore, clinical data and temporal cor-
relation with radiological findings are extremely important,
as well as correlation with previous examination findings.
In addition to these findings, CT of patients with COVID-19
may also show signs of organizing pneumonia, reversed halo
sign, reticular pattern, subpleural curvilinear lines, parench-
ymal bands, pseudocavities, and nodules, sometimes con-
figuring the halo sign (17-19). Airway centered disease
such as bronchial wall thickening, centrilobular and tree in
bud opacities, pleural effusion, and lymphadenopathy are
not frequently encountered at the initial presentation of
COVID-19 (17).
CT findings also vary according to the days of symptom
onset. GGOs are more common in the first few days of
symptom onset and can evolve to consolidations, reaching a
Figure 6 - Typical findings of COVID-19. Axial CT images show multifocal GGOs of rounded morphology with areas of consolidation.
Figure 5 - Typical findings of COVID-19. Axial CT images show
peripheral, bilateral GGOs with areas of consolidation. Note the
associated septal thickening.
Figure 7 - Typical findings of COVID-19. Axial CT image shows
GGO areas surrounded by rings of consolidation (reversed halo
sign), complete and incomplete.
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peak in pulmonary opacities between the 9th and 13th days
after symptoms onset (6,15).
The dissociation between laboratory and tomographic
findings may be seen in patients with positive RT-PCR and
absence of imaging findings and those with extensive
imaging findings and negative RT-PCR (7,20).
’ CT STRUCTURED REPORT IN COVID-19
During a pandemic, a more assertive interpretation of
CT findings related to COVID-19 has become necessary to
assist patient management. Therefore, some groups (8,21)
have proposed the elaboration of structured reports. This
type of report offers advantages in the context of high
demand of examinations and the need for prompt decisions.
For the radiologist, it helps in the elaboration of the report,
decrease the reporting time and variability, and reduce
uncertainty in reporting findings. For the referring physician,
it improves the understanding of the radiological findings
and the quality of the information transmitted, allowing
better clinical management (22). Among available classifica-
tions, the proposal by the consensus of specialists of the
Radiological Society of North America (8) has been widely
used. They propose four groups of CT findings: typi-
cal, indeterminate, atypical, and negative for COVID-19
(Figure 4) and suggest ways to report them. In our hospital,
we adapted this classification, with small reporting language
changes (Table 1).
The typical CT finding for COVID-19 consists of (1) peri-
pheral, bilateral GGO with or without consolidation or
visible intralobular lines (crazy-paving pattern) (Figure 5);
(2) multifocal GGO of rounded morphology with or without
consolidation or visible intralobular lines (crazy-paving
pattern) (Figure 6); or (3) reversed halo sign or other
findings of organizing pneumonia (Figure 7). These find-
ings are suggestive of pneumonia and viral etiology must
be included in the etiological differential diagnosis, parti-
cularly COVID-19.
The indeterminate CT appearance for COVID-19 consists
of diffuse (Figure 8), perihilar, or unilateral (Figure 9) GGO
with or without consolidation lacking a specific distribution.
Patients with few very small GGOs with a non-rounded and
non-peripheral distribution (Figure 10) are also included in
this group. In these cases, the imaging findings are non-
specific and can be observed in several diseases of non-
infectious and infectious origin, including viral pneumonia.
Although these are not a suggestive tomographic appear-
ance, the possibility of COVID-19 should not be ruled out,
especially in severe clinical cases with extensive pulmonary
opacities, or in mild cases with isolated pulmonary opacities.
Patients with pulmonary infection findings different from
those previously described above can be categorized into the
atypical appearance (Figure 11), such as isolated lobar or
segmental consolidations, discrete small nodules (centrilob-
ular and tree-in-bud appearance), lung cavitation, and
smooth interlobular septal thickening with pleural effusion
(8). In this group, imaging findings are not usually reported
in COVID-19 infection, and other etiological agents should
be considered initially.
The last group is that of patients without features sug-
gestive of pneumonia. As already discussed, a normal chest
Figure 8 - Indeterminate findings of COVID-19. Axial CT image
shows bilateral diffused GGOs associated with consolidations,
and some areas of septal thickening.
Figure 9 - Indeterminate findings of COVID-19. Axial (A) and sagittal (B) CT images show unilateral GGOs in the upper segment of the
left lower lobe.
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CT does not exclude the diagnosis of COVID-19, especially in
the initial days of symptoms onset.
In addition to this classification, the structured report
may also contain an estimate of the extent of pulmonary
involvement (e.g., describing whether it involves more or
less than 50% of the lung parenchyma), information that
has been used as one of the criteria for hospitalization (23),
and is also related to admission to intensive care units and
mortality (24,25). Such quantification may be performed
visually or automatically through specific software. Several
imaging scores (by lobes or pulmonary fields) have been
proposed (14,23,26,27), but all of them are difficult to apply
in clinical practice and more studies are needed to validate
the correlation of these quantification methods with the
clinical course of the disease.
’ ULTRASONOGRAPHY
As previously mentioned, COVID-19 alterations tend
to predominate in the lung periphery, which makes lung
ultrasound an option in the follow-up of hospitalized patients,
especially those in intensive care units, where transfer to a
CT scanner is impossible or difficult. However, this method
should not be used as a substitute for CT (5,6,28).
Its potential use as a serial assessment tool through
established protocols, such as the 12-site scanning technique
(29,30) (Figure 12), allows the evaluation of the progression of
inflammatory involvement of the parenchyma and identifica-
tion of mild findings, such as pleural thickening and even
small subpleural consolidations (Figure 13). It also reduces
environmental exposure as only a single doctor is needed
to perform the examination at bedside (5,28).
Lung ultrasound is based on artefactual lines and their
patterns. In patients with COVID-19, there are irregularly
spaced vertical artifacts, known as B-lines, which may
coalesce. Consolidations with or without air bronchograms
may also be found in these patients (28) (Figure 13). B-lines
Figure 10 - Indeterminate findings of COVID-19. Axial CT image
shows a very small GGO with a non-rounded and non-peripheral
distribution.
Figure 11 - Atypical findings of COVID-19. Axial CT images show (A) isolated segmental consolidation; (B) discrete small centrilobular
nodules, some of them with the ‘‘tree-in-bud’’ pattern; (C) lung cavitations; and (D) bilateral smooth interlobular septal thickening
with pleural effusion.
Figure 12 - Transducer sites for lung ultrasound. The six sites are anatomically divided by the parasternal line (green line), anterior
axillary line (pink line), posterior axillary line (yellow line), and paravertebral line. The subdivision in the superior and inferior takes into
account the well-established Bedside Lung Ultrasound in Emergency (BLUE) protocol.
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represent the interlobular and/or intralobular septal thicken-
ing, most associated with pulmonary edema and interstitial
disorders. When coalescent, with several B-lines grouped,
they correspond to GGO at the periphery of the lungs, as
observed on CT (31,32).
’ CONCLUSION
Imaging should be wisely indicated in the evaluation
of patients with COVID-19 to avoid unnecessary exposure
of other patients and healthcare workers and rationalize the
use of personal protective equipment. Imaging should be
reserved for patients with moderate to severe respiratory
symptoms, risk of progression (presence of comorbidities),
or worsening of the respiratory condition. It should not be
indicated for asymptomatic patients or those with mild
symptoms. In environments with limited testing resources,
imaging can eventually be indicated as a triage method for
suspected patients with high pre-test probability.
Chest CT is the main imaging method used in the eval-
uation of COVID-19 pneumonia. Typical findings include
GGOs with or without consolidation, crazy-paving pattern
with bilateral and multifocal distribution, peripheral and
posterior predominance, multifocal GGOs of rounded mor-
phology, and reversed halo sign. Additionally, CT can help
evaluate the extent of pulmonary disease, presence of com-
plications, and differential diagnosis. Despite typical CT
findings in COVID-19, RT-PCR remains the gold standard for
the diagnosis.
Structured chest CT report standardizes the imaging
findings and optimizes communication with the referring
physician, thus being a useful tool in the pandemic scenario.
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